Skip to main content
Contact Us
Subscribe
E-Edition
42°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Daseke Inc
(NQ:
DSKE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Daseke Inc
Glancy Prongay & Murray LLP Announces Investigation of Daseke, Inc. (DSKE)
April 22, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
DASEKE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Daseke, Inc. - DSKE
February 27, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX)
January 04, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
DASEKE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Daseke, Inc. - DSKE
December 31, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX)
December 26, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Daseke Inc. (NASDAQ: DSKE) Leading the Way in Friday Trading Based on Percentage Gain
December 22, 2023
Via
Investor Brand Network
DSKE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Daseke, Inc. Is Fair to Shareholders
December 22, 2023
From
Halper Sadeh LLC
Via
Business Wire
Daseke to be Acquired by TFI International
December 22, 2023
From
Daseke, Inc.
Via
GlobeNewswire
Daseke Reports Results for Third-Quarter 2023 and Updates 2023 Outlook
November 09, 2023
Advanced strategic capital allocation priorities with additional $20 million term-loan repayment, delivered enhanced operational productivity, and successfully executed One Daseke initiatives
From
Daseke, Inc.
Via
GlobeNewswire
Daseke, Inc. Schedules Third-Quarter 2023 Earnings Call November 9, 2023
October 30, 2023
From
Daseke, Inc.
Via
GlobeNewswire
Daseke Reports Results for Second-Quarter 2023 and Updates 2023 Outlook
August 03, 2023
Strong cash generation with asset-right strategy driving improvement in company loads, company miles, and company revenue
From
Daseke, Inc.
Via
GlobeNewswire
Daseke, Inc. Schedules Second-Quarter 2023 Earnings Call on August 3, 2023
July 24, 2023
From
Daseke, Inc.
Via
GlobeNewswire
Daseke Appoints Chief Operating Officer and Confirms Previously Announced Executive Leadership Transition
June 01, 2023
From
Daseke, Inc.
Via
GlobeNewswire
Daseke Reports Results for First-Quarter 2023 and Updates 2023 Outlook
May 09, 2023
From
Daseke, Inc.
Via
GlobeNewswire
Glancy Prongay & Murray LLP Announces Investigation of Daseke, Inc. (DSKE)
May 03, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
Daseke, Inc. to Release First-Quarter 2023 Results on May 9, 2023
April 18, 2023
From
Daseke, Inc.
Via
GlobeNewswire
Daseke Announces Chief Operating Officer Transition
March 03, 2023
Specialized Segment leader and transportation industry veteran, Scott Hoppe, to become EVP and COO effective June 1, 2023
From
Daseke, Inc.
Via
GlobeNewswire
Daseke Announces Record Results, Reports Fourth-Quarter and Full-Year 2022, and Provides Full-Year 2023 Outlook
February 06, 2023
Provides update on accretive fourth-quarter share repurchases
From
Daseke, Inc.
Via
GlobeNewswire
Daseke Management to Participate in Stifel 2023 Transportation & Logistics Conference
January 31, 2023
From
Daseke, Inc.
Via
GlobeNewswire
Daseke Names Adrianne D. Griffin Vice President, Investor Relations and Treasurer
January 30, 2023
Newly created role with a dedicated proven leader facilitates enhanced communication of the Company’s shareholder value proposition
From
Daseke, Inc.
Via
GlobeNewswire
Daseke, Inc. to Release Fourth-Quarter and Full-Year 2022 Results February 6, 2023
January 27, 2023
From
Daseke, Inc.
Via
GlobeNewswire
Daseke Announces Completion of Founder’s Stock Repurchase
November 21, 2022
From
Daseke, Inc.
Via
GlobeNewswire
Daseke to Participate in Two Investor Conferences
November 15, 2022
From
Daseke, Inc.
Via
GlobeNewswire
Daseke Announces Repurchase of Founder’s Stock
November 14, 2022
Company has announced a structured transaction to repurchase Founder’s 28.6% position
From
Daseke, Inc.
Via
GlobeNewswire
Daseke Reports Results for Third Quarter 2022
November 09, 2022
Confidence in full-year outlook, as strategic portfolio of end markets demonstrates resilience across industrial freight market
From
Daseke, Inc.
Via
GlobeNewswire
Daseke, Inc. to Release Third-Quarter 2022 Results November 9, 2022
October 26, 2022
From
Daseke, Inc.
Via
GlobeNewswire
Daseke Announces $40 Million Stock Repurchase Program
September 30, 2022
Buyback authorization enables opportunistic cash deployment as part of a balanced capital allocation strategy
From
Daseke, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.